China Biologic Products to Report Fourth Quarter and Fiscal Year 2012 Financial Results
BEIJING, March 8, 2013 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release fourth quarter and fiscal year 2012 financial results on Wednesday, March 13, 2013 after the market closes.
The Company's management will hold a conference call at 8:00 a.m. ET on Thursday, March 14, 2013 to discuss fourth quarter and fiscal year 2012 results. Listeners may access the call by dialing:
| U.S. toll free: |
+1 866 978 9970 |
| U.K. toll free: |
+0 800 279 7785 |
| Mainland China toll free (landline): |
800 803 6103 |
| Mainland China toll free (mobile): |
400 681 6405 |
| Hong Kong toll free: |
3027 5500 |
| International toll: |
+852 3027 5500 |
| Conference ID: |
674 477# |
A telephone replay will become available beginning two hours after the conclusion of the call and will remain available through March 20, 2013. Listeners may access the replay by dialing:
| U.S. toll free: |
+1 866 753 0743 |
| U.K. toll free: |
+0 808 234 7126 |
| Mainland China: |
800 876 5016 |
| Hong Kong: |
3027 5520 |
| International toll: |
+852 3027 5520 |
| Conference ID: |
138 012# |
About China Biologic Products, Inc.
China Biologic Products, Inc. (Nasdaq: CBPO), is a leading fully integrated plasma-based biopharmaceutical company in China. The Company's products are used as critical therapies during medical emergencies and for the prevention and treatment of life-threatening diseases and immune-deficiency related diseases. China Biologic is headquartered in Beijing and manufactures over 20 plasma-based products through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co., Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd. The Company also has an equity investment in Xi'an Huitian Blood Products Co., Ltd. The Company sells its products to hospitals and other healthcare facilities in China. For additional information, please see the Company's website www.chinabiologic.com.
Contact:
China Biologic Products, Inc.
Mr. Ming Yin
Vice President
Phone: +86-10-6598-3099
Email: [email protected]
ICR Inc.
Mr. Bill Zima
Phone: +86-10-6583-7511 or +1-646-405-5191
E-mail: [email protected]
SOURCE China Biologic Products, Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article